Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82–97.

Article  PubMed  CAS  Google Scholar 

Li L, Liu D-W, Yan H-Y, Wang Z-Y, Zhao S-H, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510–9.

Article  PubMed  CAS  Google Scholar 

Polyzos SA, Kountouras J, Mantzoros CS. Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42:92–108.

Article  PubMed  Google Scholar 

Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52:25–37.

Article  PubMed  CAS  Google Scholar 

Polyzos SA, Mantzoros CS. Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management. Metabolism. 2024;157:155936.

Polyzos SA, Kechagias S, Tsochatzis EA. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. Aliment Pharmacol Ther. 2021;54:1013–25.

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.

Article  PubMed  CAS  Google Scholar 

Polyzos SA, Kountouras J, Zavos C, Deretzi G. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol. 2012;46:272–84.

Article  PubMed  Google Scholar 

Zaidi M, Zaidi S, Yuen T. Understanding osteokine biology. Cell Metab. 2024;36:888–90.

Article  PubMed  CAS  Google Scholar 

Liang W, Wei T, Hu L, Chen M, Tong L, Zhou W, et al. An integrated multi-omics analysis reveals osteokines involved in global regulation. Cell Metab. 2024;36:1144-1163.e7.

Article  PubMed  CAS  Google Scholar 

Shimonty A, Bonewald LF, Huot JR. Metabolic health and disease: A role of osteokines? Calcif Tissue Int. 2023;113:21–38.

Article  PubMed  CAS  Google Scholar 

Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polyzos SA. Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes Obes Metab. 2022;24:1702–20.

Article  PubMed  CAS  Google Scholar 

Drapkina OM, Elkina AY, Sheptulina AF, Kiselev AR. Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives. Int J Mol Sci. 2023;24:8445.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Azizieh FY, Shehab D, Al Jarallah K, Mojiminiyi O, Gupta R, Raghupathy R. Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD. J Inflamm Res. 2019;12:99–108.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Filip R, Radzki RP, Bieńko M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging. 2018;13:1879–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016;65:1062–79.

Article  PubMed  CAS  Google Scholar 

Shu L, Fu Y, Sun H. The association between common serum adipokines levels and postmenopausal osteoporosis: A meta-analysis. J Cell Mol Med. 2022;26:4333–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Santos JPMD, de Maio MC, Lemes MA, Laurindo LF, Haber JFDS, Bechara MD, et al. Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future. Int J Mol Sci. 2022;23:498.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S, et al. Hepatic osteodystrophy-molecular mechanisms proposed to favor its development. Int J Mol Sci. 2019;20:2555.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Yavropoulou MP, Makras P. Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations. Maturitas. 2021;147:19–25.

Article  PubMed  CAS  Google Scholar 

Zhao J, Lei H, Wang T, Xiong X. Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology. Front Endocrinol. 2023;14:1161402.

Article  Google Scholar 

Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009;20:230–6.

Article  PubMed  CAS  Google Scholar 

Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Curr Osteoporos Rep. 2015;13:180–5.

Article  PubMed  Google Scholar 

Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9:299–314.

Article  PubMed  CAS  Google Scholar 

Zhang M, Nie X, Yuan Y, Wang Y, Ma X, Yin J, et al. Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A. Int J Endocrinol. 2021;2021:9178616.

Article  PubMed Central  Google Scholar 

Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50:568–75.

Article  PubMed  CAS  Google Scholar 

Du J, Zhang M, Lu J, Zhang X, Xiong Q, Xu Y, et al. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine. 2016;53:701–9.

Article  PubMed  CAS  Google Scholar 

Zhang X-L, Wang Y-N, Ma L-Y, Liu Z-S, Ye F, Yang J-H. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacol Sin. 2020;41:383–93.

Article  PubMed  CAS  Google Scholar 

Gupte AA, Sabek OM, Fraga D, Minze LJ, Nishimoto SK, Liu JZ, et al. Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome. Endocrinology. 2014;155:4697–705.

Article  PubMed  PubMed Central  Google Scholar 

Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med. 2013;19:522–35.

Article  PubMed  CAS  Google Scholar 

Otani T, Mizokami A, Kawakubo-Yasukochi T, Takeuchi H, Inai T, Hirata M. The roles of osteocalcin in lipid metabolism in adipose tissue and liver. Adv Biol Regul. 2020;78: 100752.

Article  PubMed  CAS  Google Scholar 

Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. Int J Endocrinol. 2013;2013: 846480.

Article  PubMed